RheumNow: Infection Risk in RA Rises With 2nd Biologic

RA patients who were previously treated with a biologic have an increased risk of hospitalized infections with the start of a new biologic, with a crude incidence rate of 15.3 (95% CI 14.7 to 15.9) per 100 person-years.